Skip to main content

Incannex Healthcare Ltd ADR (IXHL) Stock

Incannex Healthcare Ltd ADR Stock Details, Movements and Public Alerts

Stock Details

Incannex Healthcare Ltd ADR (IXHL), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.43. Over the past 52 weeks, it has ranged between $0.08 and $2.25. This places the current price at 19.1% of its 52-week high and 437.5% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 56.19, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.38 by 13.16%. Similarly, it is below its 200-day moving average of $0.47 by 8.51%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: 0.01, Signal Line: 0.01). There are currently 2 active alerts set for IXHL by users.

52-Week Range

$2.25 - $0.08

-80.89% from high · +437.50% from low

Avg Daily Volume

25,210,900

20-day average

100-day avg: 68,032,386

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

1.83

EV/EBITDA

-5.13

EPS (TTM)

-$1.08

Price to Sales

12204.45

Beta

2.60

More volatile than market

How is IXHL valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is IXHL's risk profile compared to the market?
With a beta of 2.60, Incannex Healthcare Ltd ADR is significantly more volatile than the market. For every 10% market move, this stock tends to move 26% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 1.83 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-191625.00%

EBITDA

$-22,850,000

Return on Equity

-114.50%

Return on Assets

-30.30%

Revenue Growth (YoY)

-100.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is IXHL's business model?
0 The operating margin of -191625.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -114.50% and ROA at -30.30%, the company achieves moderate returns on invested capital.
What are IXHL's recent growth trends?
Incannex Healthcare Ltd ADR's revenue declined by 100.00% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against DRUG MANUFACTURERS - SPECIALTY & GENERIC industry averages for proper context.

Company Size & Market

Market Cap

$146.5M

Revenue (TTM)

$12,000

Revenue/Share (TTM)

$0.00

Shares Outstanding

346.23M

Book Value/Share

$0.22

Asset Type

Common Stock

What is IXHL's market capitalization and position?
Incannex Healthcare Ltd ADR has a market capitalization of $146.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 346.23M shares outstanding, the company's ownership is relatively concentrated. As a participant in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry, it competes with other firms in this sector.
How does IXHL's price compare to its book value?
Incannex Healthcare Ltd ADR's book value per share is $0.22, while the current stock price is $0.43, resulting in a price-to-book (P/B) ratio of 1.95. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Fundamentals last updated: Dec 14, 2025, 02:02 AM

Technical Indicators

RSI (14-day)

56.19

Neutral

50-Day Moving Average

$0.38

13.16% above MA-50

200-Day Moving Average

$0.47

-8.51% below MA-200

MACD Line

0.01

MACD Signal

0.01

MACD Histogram

0.01

Bullish

What does IXHL's RSI value tell investors?
The RSI (Relative Strength Index) for IXHL is currently 56.19, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret IXHL's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.01 below the signal line at 0.01, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.38) is below the 200-day MA ($0.47), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Dec 15, 2025, 12:33 AM

Active Alerts

Alert Condition
Price increases by
Threshold
15%
Created
Dec 12, 2025, 03:54 PM
Alert Condition
Volume change
Threshold
200%
Created
Dec 12, 2025, 03:54 PM

Stay Ahead of the Market with Incannex Healthcare Ltd ADR Alerts

Set up price alerts for Incannex Healthcare Ltd ADR and get notified instantly when the price hits your target. Never miss an important price movement again.